Novo Nordisk settles Minnesota insulin pricing case: report

Novo Nordisk (NVO) has reportedly settled a lawsuit filed by the state of Minnesota over the pricing of its insulin products by agreeing to cap costs at $35 per month.

Under the settlement, Novo Nordisk (NVO) will cap out-of-pocket